The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Open accessAbstract
BACKGROUND: Lp(a) lipoprotein binds proinflammatory oxidized phospholipids. We investigated whether levels of oxidized low-density lipoprotein (LDL) measured with use of monoclonal antibody E06 reflect the presence and extent of obstructive coronary artery disease, defined as a stenosis of more than 50 percent of the luminal diameter. METHODS: Levels of oxidized LDL and Lp(a) lipoprotein were measured in a total of 504 patients immediately before coronary angiography. Levels of oxidized LDL are reported as the oxidized phospholipid content per particle of apolipoprotein B-100 (oxidized phospholipid:apo B-100 ratio). RESULTS: Measurements of the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels were skewed toward lower values, and the values for the oxidized phospholipid:apo B-100 ratio correlated strongly with those for Lp(a) lipoprotein (r=0.83, P<0.001). In the entire cohort, the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels showed a strong and graded association with the presence and extent of coronary artery disease (i.e., the number of vessels with a stenosis of more than 50 percent of the luminal diameter) (P<0.001). Among patients 60 years of age or younger, those in the highest quartiles for the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels had odds ratios for coronary artery disease of 3.12 (P<0.001) and 3.64 (P<0.001), respectively, as compared with patients in the lowest quartile. The combined effect of hypercholesterolemia and being in the highest quartiles of the oxidized phospholipid:apo B-100 ratio (odds ratio, 16.8; P<0.001) and Lp(a) lipoprotein levels (odds ratio, 14.2; P<0.001) significantly increased the probability of coronary artery disease among patients 60 years of age or younger. In the entire study group, the association of the oxidized phospholipid:apo B-100 ratio with obstructive coronary artery disease was independent of all clinical and lipid measures except one, Lp(a) lipoprotein. However, among patients 60 years of age or younger, the oxidized phospholipid:apo B-100 ratio remained an independent predictor of coronary artery disease. CONCLUSIONS: Circulating levels of oxidized LDL are strongly associated with angiographically documented coronary artery disease, particularly in patients 60 years of age or younger. These data suggest that the atherogenicity of Lp(a) lipoprotein may be mediated in part by associated proinflammatory oxidized phospholipids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Dahlen, G. H., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.758 · Cited by 911
Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction
Rhoads, G. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380180102027 · Cited by 783
Ehara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.15.1955 · Cited by 781
Binder, C. J., Hörkkö, S., Dewan, A., Chang, M.-K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., & Silverman, G. J. (2003) · Nature Medicine · doi:10.1038/nm876 · Cited by 737
Self-citationShaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Self-citationHolvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., & Collen, D. (1998) · Circulation · doi:10.1161/01.cir.98.15.1487 · Cited by 673
Innate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Self-citationCirculating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease
Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., & Van de Werf, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.844 · Cited by 530
Chang, M.-K., Binder, C. J., Torzewski, M., & Witztum, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192399699 · Cited by 521
Self-citationBinder, C. J., Hartvigsen, K., Chang, M.-K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., & Witztum, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420479 · Cited by 452
Self-citationAssmann, G., Schulte, H., & von Eckardstein, A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00159-2 · Cited by 447
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
Sandkamp, M., Funke, H., Schulte, H., Köhler, E., & Assmann, G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.1.20 · Cited by 417
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability
Nishi, K., Itabe, H., Uno, M., Kitazato, K. T., Horiguchi, H., Shinno, K., & Nagahiro, S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033829.14012.18 · Cited by 409
Toshima, S.-I., Hasegawa, A., Kurabayashi, M., Itabe, H., Takano, T., Sugano, J., Shimamura, K., Kimura, J., Michishita, I., Suzuki, T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2243 · Cited by 407
Transient changes of serum lipoprotein(a) as an acute phase protein
Maeda, S., Abe, A., Seishima, M., Makino, K., Noma, A., & Kawade, M. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90218-9 · Cited by 365
Tsimikas, S., Bergmark, C., Beyer, R. W., Patel, R., Pattison, J., Miller, E., Juliano, J., & Witztum, J. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02769-9 · Cited by 349
Self-citationApoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory
Chang, M.-K., Binder, C. J., Miller, Y. I., Subbanagounder, G., Silverman, G. J., Berliner, J. A., & Witztum, J. L. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031763 · Cited by 335
Self-citationTsimikas, S., Lau, H. K., Han, K.-R., Shortal, B., Miller, E. R., Segev, A., Curtiss, L. K., Witztum, J. L., & Strauss, B. H. (2004) · Circulation · doi:10.1161/01.cir.0000130844.01174.55 · Cited by 285
Self-citationCushing, G. L., Gaubatz, J. W., Nava, M. L., Burdick, B. J., Bocan, T. M., Guyton, J. R., Weilbaecher, D., DeBakey, M. E., Lawrie, G. M., & Morrisett, J. D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.593 · Cited by 252
Tsimikas, S., Witztum, J. L., Miller, E. R., Sasiela, W. J., Szarek, M., Olsson, A. G., & Schwartz, G. G. (2004) · Circulation · doi:10.1161/01.cir.0000141728.23033.b5 · Cited by 225
Self-citationWolk, R., Berger, P., Lennon, R. J., Brilakis, E. S., & Somers, V. K. (2003) · Circulation · doi:10.1161/01.cir.0000095270.85646.e8 · Cited by 184
Self-citationLipoprotein(a): intrigues and insights
Hobbs, H. H., & White, A. L. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00005 · Cited by 179
Measuring Circulating Oxidized Low-Density Lipoprotein to Evaluate Coronary Risk
Tsimikas, S., & Witztum, J. L. (2001) · Circulation · doi:10.1161/01.cir.103.15.1930 · Cited by 155
Self-citationDangas, G., Mehran, R., Harpel, P. C., Sharma, S. K., Marcovina, S. M., Dube, G. K., Ambrose, J. A., & Fallon, J. T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00469-0 · Cited by 144
Edelstein, C., Pfaffinger, D., Hinman, J., Miller, E. R., Lipkind, G. M., Tsimikas, S., Bergmark, C., Getz, G. S., Witztum, J. L., & Scanu, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310425200 · Cited by 137
Self-citationBerg, K., Dahlén, G. H., Christophersen, B. O., Cook, T. J., KJEKSHUS, J. K., & Pedersen, T. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb04342.x · Cited by 136
Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
Holvoet, P. (1999) · JAMA · doi:10.1001/jama.281.18.1718 · Cited by 127
Blencowe, C., Hermetter, A., Kostner, G. M., & Deigner, H. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31151 · Cited by 104
Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Foody, J. M., MILBERG, J. A., Robinson, K., Pearce, G. L., Jacobsen, D. W., & Sprecher, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.493 · Cited by 103
Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions
Karabina, S.-A. P., Liapikos, T. A., Grekas, G., Goudevenos, J. A., & Tselepis, A. D. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90219-4 · Cited by 82
Holvoet, P., Peeters, K., Lund‐Katz, S., Mertens, A. C., Verhamme, P. B., Quarck, R. A., Stengel, D., Lox, M., Deridder, E., Bernar, H., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100221 · Cited by 79
Hearn, J. A., DeMaio, S. J., Roubin, G. S., Hammarström, M., & Sgoutas, D. S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91094-m · Cited by 75
Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods
McConnell, J. P., Branum, E. L., Ballman, K. V., Lagerstedt, S. A., Katzmann, J. A., & Jaffe, A. S. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.011 · Cited by 73
Self-citationStimulation of Interleukin-8 Production in Human THP-1 Macrophages by Apolipoprotein(a)
Klezovitch, O., Edelstein, C., & Scanu, A. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107943200 · Cited by 68
Immunolocalization of Lipoprotein(a) in Wounded Tissues
Yano, Y., Shimokawa, K., Okada, Y., & Noma, A. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500408 · Cited by 58
Sunayama, S., Daida, H., Mokuno, H., Miyano, H., Yokoi, H., Lee, Y. J., Sakurai, H., & Yamaguchi, H. (1996) · Circulation · doi:10.1161/01.cir.94.6.1263 · Cited by 56
Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity
Thillet, J., Doucet, C., Chapman, J., Herbeth, B., Cohen, D., & Faure-Delanef, L. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00217-7 · Cited by 54
Cited by
WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,289
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.015 · Cited by 1,692
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Metadata
- Authors
- Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-07-07
- Volume
- 353
- Issue
- 1
- Pages
- 46-57
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130541883
- Cited by
- 784
- References
- 39
- FWCI
- 47.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.